Jacobs Levy Equity Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-38,833
Closed -$447K 1063
2024
Q3
$447K Buy
38,833
+11,670
+43% +$134K ﹤0.01% 846
2024
Q2
$307K Buy
27,163
+15,163
+126% +$202K ﹤0.01% 891
2024
Q1
$172K Buy
+12,000
New +$170K ﹤0.01% 899
2022
Q4
Sell
-15,640
Closed -$137K 1056
2022
Q3
$137K Sell
15,640
-265,524
-94% -$2.76M ﹤0.01% 951
2022
Q2
$2.8M Sell
281,164
-69,869
-20% -$703K 0.02% 525
2022
Q1
$3.53M Buy
351,033
+197,200
+128% +$2.1M 0.02% 493
2021
Q4
$1.95M Buy
153,833
+9,082
+6% +$118K 0.01% 624
2021
Q3
$1.81M Buy
+144,751
New +$1.96M 0.01% 630

Other funds holding PTVE

Jacobs Levy Equity Management's PTVE Position: Q4 2024 in Review

Jacobs Levy Equity Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2024, closing a stake of 38,833 shares — an estimated $447K sold.

Jacobs Levy Equity Management first reported a position in PTVE in Q3 2021 and held it in 8 quarters. The position peaked at $3.53M in Q1 2022. 161 funds tracked by Wall St. Rank hold PTVE as of Q4 2024.

  • Jacobs Levy Equity Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 38,833 Pactiv Evergreen Inc. Common stock shares in Q4 2024, an estimated $447K.
  • Jacobs Levy Equity Management first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2021 and held it in 8 quarters.
  • Jacobs Levy Equity Management's Pactiv Evergreen Inc. Common stock position peaked at $3.53M in Q1 2022.
  • 161 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.